Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
Go back to Kyverna Therapeutics Names Greg Martini as Chief Financial Officer| (NASDAQ: KYTX) | Delayed: 5.69 -0.08 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.77 | 52 Week High | $ | |||
| Open | $5.76 | 52 Week Low | $ | |||
| Day High | $5.85 | P/E | N/A | |||
| Day Low | $5.61 | EPS | $ | |||
| Volume | 1,275,813 | |||||



